Stryker Corporation $SYK Stock Holdings Raised by Raiffeisen Bank International AG

Raiffeisen Bank International AG lifted its stake in shares of Stryker Corporation (NYSE:SYK) by 2.8% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 88,280 shares of the medical technology company’s stock after buying an additional 2,388 shares during the quarter. Raiffeisen Bank International AG’s holdings in Stryker were worth $32,653,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Bridgewater Advisors Inc. raised its position in shares of Stryker by 4.4% during the 3rd quarter. Bridgewater Advisors Inc. now owns 1,944 shares of the medical technology company’s stock valued at $719,000 after acquiring an additional 82 shares in the last quarter. China Universal Asset Management Co. Ltd. acquired a new position in Stryker in the third quarter worth $741,000. Marshall & Sterling Wealth Advisors Inc. raised its holdings in shares of Stryker by 25.5% during the third quarter. Marshall & Sterling Wealth Advisors Inc. now owns 639 shares of the medical technology company’s stock worth $230,000 after purchasing an additional 130 shares during the period. Fiera Capital Corp lifted its position in shares of Stryker by 24.5% in the 3rd quarter. Fiera Capital Corp now owns 28,828 shares of the medical technology company’s stock worth $10,657,000 after buying an additional 5,667 shares during the last quarter. Finally, Burling Wealth Partners LLC boosted its holdings in shares of Stryker by 34.6% in the 3rd quarter. Burling Wealth Partners LLC now owns 11,743 shares of the medical technology company’s stock valued at $4,341,000 after buying an additional 3,021 shares during the period. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on SYK shares. Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a research note on Monday, December 22nd. Evercore set a $390.00 price target on Stryker in a research report on Monday, January 5th. Truist Financial lowered their price objective on Stryker from $400.00 to $392.00 and set a “hold” rating for the company in a research note on Thursday, December 18th. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Sanford C. Bernstein lifted their price objective on shares of Stryker from $450.00 to $465.00 and gave the company an “outperform” rating in a research note on Friday, January 9th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $426.94.

Insider Buying and Selling

In other Stryker news, Director Ronda E. Stryker sold 250,000 shares of Stryker stock in a transaction that occurred on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total value of $90,730,000.00. Following the transaction, the director directly owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. The trade was a 9.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 5.90% of the stock is owned by company insiders.

Stryker Trading Up 2.0%

Shares of SYK opened at $380.15 on Friday. The business’s 50-day moving average price is $360.05 and its 200 day moving average price is $368.95. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $145.48 billion, a P/E ratio of 45.26, a P/E/G ratio of 2.18 and a beta of 0.87. Stryker Corporation has a 1-year low of $329.16 and a 1-year high of $404.87.

Stryker (NYSE:SYK) last posted its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping analysts’ consensus estimates of $4.40 by $0.07. The company had revenue of $7.17 billion during the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.The business’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period last year, the business earned $4.01 EPS. Analysts expect that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 dividend on an annualized basis and a dividend yield of 0.9%. Stryker’s dividend payout ratio (DPR) is currently 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.